The FDA announced that 7,107 bottles of Duloxetine Delayed-Release Capsules – sold under the brand name Cymbalta – have been recalled due to containing a potentially cancer-causing chemical. The FDA announced that 7,107 bottles of Duloxetine Delayed-Release Capsules – sold under the brand name Cymbalta – have been recalled due to containing a potentially cancer-causing chemical.